Japan Invests in RNAi to Tackle Genetic and Neurodegenerative Diseases
The global RNAi Technology Market was valued at USD 1.6 billion in 2022 and is projected to reach USD 3.6 billion by 2031, growing at a CAGR of 10.3% during the forecast period 2024–2031. RNA interference (RNAi) utilizes small nucleic acid fragments to silence genes post-transcriptionally, enabling the treatment of cancer and other complex disorders with high specificity. This technique...
0 Comments 0 Shares 5 Views 0 Reviews